Insparin Therapeutics is pioneering the development of a first-in-class therapy for Severe Insulin Resistance (SIR) and Severe Insulin Resistance Syndromes (SIRS), including several rare, orphan-desig ...

Intra-Cellular Therapies Inc., a Johnson & Johnson Company, is a biopharmaceutical company focused on the discovery, clinical development and commercialization of innovative, small molecule drugs that ...

ICEX Spain Trade and Investment is a public corporation at the national level aimed to promote the internationalisation of Spanish companies to support their competitiveness and add value to the econo ...

ICR Healthcare is a leading global strategic communication, investor relations and capital markets advisory firm specializing in the healthcare sector.

IgGenix is a clinical-stage, venture backed company using single cell transcriptomics to isolate rare IgE producing B cells directly from patients and discover novel antibody therapeutics. Our lead pr ...

IGNITE Photonics Foundation is a 501(c)(3) nonprofit investor making mission-aligned, program-related equity investments in pre-seed and seed-stage companies at the biotech and optics/photonics interf ...

IMMEDIATE Therapeutics (IMMTX) is advancing IMT-358, a first-in-class metabolic cardioprotective therapy targeting the largest remaining unmet need in acute cardiovascular care: protecting myocardium ...

Incendia is a clinical stage company targeting the tumor microenvironment. Our most advanced program is preparing to enter Ph2 trial in 2026. The Company is also advancing a diverse pipeline of curren ...